Eli Lilly and Company (NYSE:):
This non-tech mega cap, that is part of the top 10 or top 15 companies in the by market cap, has been hammered after the last earnings report, finding once again support at the $700 zone (November 2024, April 2025, and May 2025), which is the lower edge of the volume profile. The recent MACD crossover suggests this bounce has more fuel.
Right now, the price is facing the 50 daily moving average in confluence with the upper Bollinger band. Some consolidation is…
Article Source
https://www.investing.com/analysis/2-giants-in-different-technical-stages-eli-lilly-and-broadcom-200661761